PrimeRFP SCOUT · Federal Contract Recompete Brief

W9114F25FA037Ortho-vision analyzer consumables for the — Ortho-Clinical Diagnostics Gmbh

Ortho-Clinical Diagnostics Gmbh holds $766K across 12 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrco Europe

Awarding office

Ortho-Clinical Diagnostics Gmbh

Recipient

Sep 30, 2026

PoP end

$178K

Obligated

$178K

Potential

325413

NAICS

6550

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics Gmbh — $90

Contract facts

NONE

Contract numberW9114F25FA037

Also listed asW9114F24A0010-W9114F25FA037

AgencyW40m Mrco Europe

Awarding officeW40m Mrco Europe

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentOrtho-Clinical Diagnostics Gmbh

CAGEDB116

UEIGM5SLSX6DLH5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVW9114F24A0010

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startOct 1, 2025

PoP end (current)Sep 30, 2026

Obligated$178K

Current value$178K

Potential value$178K

ORTHO-VISION ANALYZER CONSUMABLES FOR THE LANDSTUHL REGIONAL MEDICAL CENTER, DPALS is a federal NONE award for W40m Mrco Europe held by Ortho-Clinical Diagnostics Gmbh. Estimated value $178K ($178K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder.

ORTHO-VISION ANALYZER CONSUMABLES FOR THE LANDSTUHL REGIONAL MEDICAL CENTER, DPALS

Recompete timing

Public

● Expiring in 23 days

Current PoP ends Sep 30, 2026 (23 days remaining). Agencies typically plan 12–18 months ahead — at 0.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics Gmbh — $766K obligated across 12 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($766K) · all agencies

Department of Defense (DOD)$754K · 98%Department of Veterans Affairs (VA)$13K · 2%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W9114F25FA037?

W9114F25FA037 (Ortho-vision analyzer consumables for the) is a W40m Mrco Europe award with a potential value of $178K, currently held by Ortho-Clinical Diagnostics Gmbh. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W9114F25FA037?

W40m Mrco Europe awarded W9114F25FA037 to Ortho-Clinical Diagnostics Gmbh (potential $178K).

Who is the incumbent on W9114F25FA037?

Ortho-Clinical Diagnostics Gmbh is the incumbent with $766K across 12 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics Gmbh’s W9114F25FA037 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W9114F25FA037 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 27, 2026